A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: cruelty (1), gravity (15)

Food labelling - patient information

Description
This factsheet contains information about food labelling laws in the UK and describes the meaning of 'may contain traces' food labels
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Foodlabelling-930-PIL.pdf

Azacitidine5

Description
Chemotherapy Protocol Myelodysplastic Syndrome (MDS) Acute Myeloid Leukaemia (AML) Chronic Myelomonocytic Leukaemia (CMML) Azacitidine SC (5 days) This is an unlice
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine5.pdf

Azacitidine5+2Ver1

Description
Chemotherapy Protocol Myelodysplastic Syndrome (MDS) Acute Myeloid Leukaemia (AML) Chronic Myelomonocytic Leukaemia (CMML) Azacitidine SC (5+2 days) This is not a l
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Azacitidine5-2Ver1.pdf

Privacy-notice-DIGNTIY-one-year (1)

Description
The Distribution of Highly Sensitive Troponin in the Critically Unwell and Associated Mortality – one year follow up. This is a privacy noti
Url
/Media/Southampton-Clinical-Research/Downloads/Privacy-notice-DIGNTIY-one-year-1.pdf

Your baby's home oxygen therapy - patient information

Description
This factsheet explains what home oxygen therapy is and what it involves, so you know what to expect when your baby
Url
/Media/UHS-website-2019/Patientinformation/Neonatal/Your-babys-home-oxygen-therapy-3883-PIL.pdf

Surgery for severe endometriosis - patient information

Description
This factsheet explains what endometriosis is, what the surgery for severe endometriosis involves and the possible risks of having the surgery
Url
/Media/UHS-website-2019/Patientinformation/Womenshealth/Surgery-for-severe-endometriosis-2261-PIL.pdf

Quality account 24-25 final

Description
QUALITY ACCOUNT 2024/25 QUALITY ACCOUNT Contents Part 1: Statement on quality from the chief executive 1.1 Chief executive’s statement
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/quality-account-24-25-final1.pdf

Atezolizumab (1875mg 21-days) SC

Description
Chemotherapy Protocol UROTHELIAL CANCER Atezolizumab SC (1875mg – 21 days) Regimen • Urothelial cancer – Atezolizumab monotherapy (1st o
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab-SC-1875mg-21-days.pdf

Capecitabine-TrastuzumabIV-Tucatinib

Description
Chemotherapy Protocol BREAST CANCER Capecitabine–Trastuzumab (IV)-Tucatinib Regimen • Breast Cancer – Capecitabine–Trastuzumab (IV)-Tucatinib Indicati
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Capecitabine-Trastuzumab-IV-Tucatinib.pdf

Cemiplimab

Description
Chemotherapy Protocol SKIN CANCER Cemiplimab (350mg) Regimen  Skin – Cemiplimab (350mg) Indication  Metastatic or locally advanced cutaneous squamous cell ca
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Cemiplimab.pdf
91 to 100 of 156
Previous … 8 9 10 11 12 … Next